These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 11376349

  • 1. [In vitro activity of linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus].
    Pérez L, Alarcón T, Jiménez S, de Las Cuevas MC, López-Brea S.
    Rev Esp Quimioter; 2001 Mar; 14(1):47-50. PubMed ID: 11376349
    [Abstract] [Full Text] [Related]

  • 2. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M, Yazgi H, Aktaş E, Ayyildiz A, Parlak M.
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics.
    Samra Z, Ofer O, Shmuely H.
    Isr Med Assoc J; 2005 Mar; 7(3):148-50. PubMed ID: 15792257
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
    Jacqueline C, Caillon J, Le Mabecque V, Miegeville AF, Donnio PY, Bugnon D, Potel G.
    J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
    [Abstract] [Full Text] [Related]

  • 5. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections.
    Stein GE, Schooley S, Peloquin CA, Missavage A, Havlichek DH.
    J Antimicrob Chemother; 2007 Oct; 60(4):819-23. PubMed ID: 17673476
    [Abstract] [Full Text] [Related]

  • 6. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Sacar M, Sacar S, Kaleli I, Onem G, Turgut H, Goksin I, Ozcan V, Kaan Inan B, Duver H, Baltalarli A.
    J Surg Res; 2007 May 15; 139(2):170-5. PubMed ID: 17292421
    [Abstract] [Full Text] [Related]

  • 7. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.
    Baysallar M, Kilic A, Aydogan H, Cilli F, Doganci L.
    Int J Antimicrob Agents; 2004 May 15; 23(5):510-2. PubMed ID: 15120733
    [Abstract] [Full Text] [Related]

  • 8. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT, Liao CH, Teng LJ, Hsueh PR.
    Clin Microbiol Infect; 2008 Feb 15; 14(2):124-9. PubMed ID: 18076671
    [Abstract] [Full Text] [Related]

  • 9. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
    Jørgen B, Merckoll P, Melby KK.
    Scand J Infect Dis; 2007 Feb 15; 39(11-12):1059-62. PubMed ID: 17852934
    [Abstract] [Full Text] [Related]

  • 10. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M, Hidalgo Orozco R, Rodríguez Garrido S, Gaona Álvarez C, Sánchez Silos RM, Hernández Rastrollo R, Martínez Tallo E, Cordero Carrasco JL.
    Rev Esp Quimioter; 2012 Mar 15; 25(1):25-30. PubMed ID: 22488538
    [Abstract] [Full Text] [Related]

  • 11. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].
    Efe S, Sinirtaş M, Ozakin C.
    Mikrobiyol Bul; 2009 Oct 15; 43(4):639-43. PubMed ID: 20084917
    [Abstract] [Full Text] [Related]

  • 12. The post-antibiotic effects of linezolid against Gram-positive pathogens.
    Hosgor-Limoncu M, Ermertcan S, Tasli H, Aydemir S.
    Saudi Med J; 2007 Apr 15; 28(4):551-4. PubMed ID: 17457476
    [Abstract] [Full Text] [Related]

  • 13. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G, White R, Friedrich L.
    J Antimicrob Chemother; 2007 Oct 15; 60(4):788-94. PubMed ID: 17623693
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro susceptibility of staphylococci to linezolid and other antimicrobial agents.
    Poiată A, Tuchiluş C, Bădicuţ I, Grigore L, Buiuc D.
    Roum Arch Microbiol Immunol; 2002 Oct 15; 61(4):293-9. PubMed ID: 15055263
    [Abstract] [Full Text] [Related]

  • 16. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
    Kuti JL, Kiffer CR, Mendes CM, Nicolau DP.
    Clin Microbiol Infect; 2008 Feb 15; 14(2):116-23. PubMed ID: 18076672
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China.
    Wang H, Liu Y, Sun H, Xu Y, Xie X, Chen M.
    Diagn Microbiol Infect Dis; 2008 Oct 15; 62(2):226-9. PubMed ID: 18653301
    [Abstract] [Full Text] [Related]

  • 18. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.
    Pillai SK, Sakoulas G, Wennersten C, Eliopoulos GM, Moellering RC, Ferraro MJ, Gold HS.
    J Infect Dis; 2002 Dec 01; 186(11):1603-7. PubMed ID: 12447736
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program.
    Ross JE, Anderegg TR, Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 May 01; 52(1):53-8. PubMed ID: 15878443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.